Africa CDC Centres for Disease Control and Prevention
6
African Union
6
OPAS
6
G. Ayala
5
J. Bear
5
J. Butler
5
Organização Mundial da Saúde (OMS)
5
World Health Organisation (WHO)
5
World Health Organization (WHO)
5
World Health Organization
4
Ministerio de Salud Argentina
3
Organización Mundial de la Salud OMS
3
Pan American Health Organization (PAHO)
3
UNFPA
3
WHO
3
Dirección de Control de Enfermedades Inmunoprevenibles
2
GPC
2
Ministerio de Salud Pública de Ecuador
2
OPAS, OMS
2
Organisation mondiale de la Santé
2
Partnership for Evidence-Based Response to COVID-19 (PERC)
2
Sallam, M.
2
The DHS Program
2
UN Relief and Works Agency for Palestine Refugees in the Near East
2
UNICEF
2
USAID
2
World Health Organization WHO
2
World Health Organization WHO, et al.
2
, UNICEF
1
A. García-Prado, J.P. Sarmiento, et al.
1
A. Sharma
1
A. Welbourn
1
African Union, African CDC, World Health Organisation
1
Amnesty International
1
Amterdam Institute for Global health & Development aighd
1
and A. Kent
1
Argote P., Barhan E., Zukerman Daly S. et al.
1
Arrieta, A.
1
Aten, J.
1
AVAC
1
AVAC (Global Advocacy for HIV Prevention)
1
Avert
1
Bagattini AM, de Melo Tavares B, Garcia Moraes Pagano C, et al.
1
Briedenhann, I., Greensides, D., Mullick, S., Ferrigno, B., Schirmer, A. & Subedar, H.
1
British Society for Immunology
1
Brown C.M., Slavinski S., Ettestad P. et al
1
C. M. Chern
1
Carolina L.A. Barbieri, C. Carvalho de Souza Amorim Matos
1
CDC
1
Center for Public Interest Communications, University of Florida
1
Centre d’études stratégiques de l’Afrique
1
Clinical Drug Information, Inc. and its affiliates and
1
Coalition for Epidemic Preparedness Innovations (CEPI)
1
Corfmat, J.
1
Couto,M.T.
1
D. Fung
1
D. Yu
1
Deborah Armbruster, Diana Beck, Susan Goldman, Phyllis Long
1
E. Levy Yeyati
1
Emanuel, E.J., et al.
1
et al
1
et al. (Джеймса Баера
1
et al.)
1
European & Developing Countries Clinical Trials Partnership EDCTTP
1
European Centre for Disease Prevention and Control ECDC
1
Extended Programme on Immunisation NDoH
1
F. Anam
1
F. Filippini
1
F. Zerbinato Bispo Velasco, de Oliveira Pedroza, G.G. et al.
1
Florida International University
1
Fondo de Población de las Naciones Unidas
1
Fonds des Nations Unies pour la population
1
Food and Agriculture Organization of the United Nations FAO
1
Frase N. S.
1
Fundo de População das Nações Unidas
1
GAVI
1
Ghana Statistical Service Accra, Ghana Health Service Accra, Ghana
1
Gibson, A.
1
Global Advocacy for HIV Prevention (AVAC)
1
Global Financing Facility (GFF)
1
Global Fund Advocates Network
1
GMDAC, University of Potsdam
1
Government of the Republic of Moldova United Nations in Moldova
1
Government of the United Kingdom
1
Gromek K., Hung M., Montero N. et al
1
Haarmann, E.
1
Health Service Excecutive HSE Ireland
1
hrp
1
Humanitarian Disaster Institute
1
IACAPAP
1
ICW Latina
1
ICW WA
1
Imperial College COVID-19 Response Team
1
International HIV/AIDS Alliance
1
International Institute for Population Sciences (IIPS) and ICF
1
International Pharmaceutical Federation FIP
1
Internews
1
Ipsos
1
J. Ananworanich
1
J. Tjaden
1
Julia Samuelson, Rachel Baggaley, Gottfried Hirnschall et al
1
Kelsey Simmons, Zuki Mihyo and Lyn Messner
1
L. Aparecida de Souza Teles and E.G. da Silva Andrade
1
L.Davies
1
M.Johnson
1
Magalhães, C.R.
1
Management Sciences for Health
1
Mediscript Ltd
1
Ministerio da Saude Brasilia
1
Ministerio da Saude do Brasil
1
Ministerio de Salud El Salvador
1
Ministerio de Salud y Protección Social Bogotá, Colombia
1
Ministère de la Santé, Direction de la Programmation et de la Prospective, Bénin
1
Ministério da Saúde
1
Ministério da Saúde Brasil
1
Ministério da Saúde, Brasil
1
Ministrerio das Saude do Brasil
1
Ministry of health
1
Ministry of Health and Family Welfare
1
Ministry of Health& Family Welfare, Goverment of India
1
Ministry of Health, Division of Community Health Services, Division of Non-Communicable Diseases
1
Ministry of Health, Kenya
1
Multiple Sclerosis international federation
1
National Association of State Public Health Veterinarians Compendium of Animal Rabies Prevention and Control Committee
1
nature communications
1
NDoH South Africa
1
Neil M Ferguson, Daniel Laydon, Gemma Nedjati-Gilani, Natsuko Imai, Kylie Ainslie, Marc Baguelin, Sangeeta Bhatia, Adhiratha Boonyasiri, Zulma Cucunubá, Gina Cuomo-Dannenburg, Amy Dighe, Ilaria Dorigatti, Han Fu, Katy Gaythorpe, Will Green, Arran Hamlet, Wes Hinsley, Lucy C Okell, Sabine van Elsland, Hayley Thompson, Robert Verity, Erik Volz, Haowei Wang, Yuanrong Wang, Patrick GT Walker, Caroline Walters, Peter Winskill, Charles Whittaker, Christl A Donnelly, Steven Riley, Azra C Ghani.
1
Niederberger,E.
1
NPJ
1
OCHA
1
OECD
1
Office for the Coordination of Humanitarian Affairs OCHA
1
Organisation Mondiale de la Santé OMS
1
Organización Mundial de la Salud
1
Organización Mundial de Saude and OPAS
1
Organización Panamericana de la Salud
1
Organização Mundial da Saúde
1
Organização Pan-Americana da Saúde e Ministério da Saúde
1
PACK
1
Padilla, M.
1
PAHO
1
Pan American Health Organization PAHO
1
Pope Francis
1
R. Pendse
1
R.M. de Oliveira Costa et al.
1
RCCE Collective Service
1
Regional Office for Africa
1
Rodrigues da Silva, M.
1
S. Dilmitis
1
S. Gupta
1
S. Sarkar
1
S.Kinloch-de Loës, et al.
1
Sage Working Group on Vaccine Hesitancy
1
SAVE THE CHILDREN
1
Secretaria Extraordinária de Enfrentamento à COVID-19, Brasil
1
Secretaria Municipal de Saúde do Rio de Janeiro
1
SUBPAV, SMS-Rio
1
T. Z. Ting Fang
1
The DHS Program ICF
1
The Independent Panel
1
The Republic of the Union of Myanmar, Ministry of Health and Sports
1
The Strengthening High Impact Interventions for an AIDS-free Generation (AIDSFree) Project
1
UN Children's Fund UNICEF
1
UN Office for the Coordination of Humanitarian Affairs
1
UNAIDS (Joint United Nations Programme on HIV
1
UNAIDS (Joint United Nations Programme on HIV/AIDS)
1
UNHCR
1
UNICF
1
United Nations Children’s Fund UNICEF
1
United Nations Population Fund
1
United States Conference of Catholic Bishops
1
V. Turmine, C. Homm
1
Vatican Press
1
Wesern Cape Government, South Africa
1
Wits RHI (University of the Witwatersrand)
1
Wolters Kluwer
1
World Health Organisation WHO
1
World Health Organization South-East Asia Region
1
World Health Organization WHO, CDC
1
Yale, G.
1
Yuen K. Y.
1
Дженнифер Батлер
1
Джорджа Айалы
1
Фонд Организации Объединенных Наций в области народонаселения
1
Publication Years
2020-2024
149
2010-2019
23
2000-2009
2
Category
COVID-19
51
Guidelines
23
Studies & Reports
12
Vaccine-preventable Diseases
6
Demograhic Health Surveys DHS
6
Community Health
6
Information, Education and Communication (IEC)
5
Humanitarian Crisis
5
Immunization
4
Policies
3
Capacity Building
3
Hepatitis
2
HIV & STI
2
Disease Prevention & Control
2
Communicable Diseases
1
Pharmacy & Technology
1
Laboratory Waste
1
General Guidelines
1
Maternal & Child Health
1
IEC Material
1
Virology
1
Policies & Guidelines HIV & TB
1
Drugs & Medical Equipment
1
Women & Child Health
1
Communicable Diseases
1
Health Systems
1
Laboratory Quality Assurance
1
Reproductive Health
1
Toolboxes
Country specific documents
30
Communication Material
15
Vaccine Hesitancy & Myths
10
Access & Strategy
7
Immunization Guidelines
7
Logistics & Supply
7
HIV in Key Populations
6
Policies
5
Men who have sex with men (MSM)
5
For General Public & Community
5
ART Drug Resistance
4
Prevention Guidelines
4
Global
4
Fair Allocation & Ethical Aspects
4
Biontech/Pfizer Comirnaty
4
Reports & Studies
4
General Reports
3
Universal Health Coverage UHC and 90-90-90 Strategy
3
COVID-19 Information
3
Global Impact: Socio-economic, health services, TB & HIV
The global impact of COVID-19 has been profound, and the public health threat it represents is the most serious seen in a respiratory virus since the 1918 H1N1 influenza pandemic. Here we present the results of epidemiological modelling which has informed policymaking in the UK and other countries i...n recent weeks.more
Available in English, French, Portuguese and Arabic
Successful immunization of a critical mass of the African population with one or several safe and efficacious COVID-19 vaccines.Key objectives1. Accelerate African involvement in the clinical development of a vaccine. 2. Ensur...e African countries can access a sufficient share of the global vaccine supply.3. Remove barriers to widespread delivery and uptake of effective vaccines across Africa.more
Will COVID-19 vaccines be safe? Will all the COVID-19 candidate vaccines be successful? What are the different phases a vaccine must go through to be approved? This document provides responses to the most frequently asked questions about candidate vaccines and access to COVID-19 vaccination.
This document is part three in a series of explainers on vaccine development and distribution. Part one focused on how vaccines work to protect our bodies from disease-carrying germs. Part two focused on the ingredients in a vaccine and the three clinical trial phases.
This document outlines the... next part of the vaccine journey: the steps from completing the clinical trial phases through to distribution.more
Herd immunity by mass vaccination offers the potential to substantially limit the continuing spread of COVID-19, but high levels of vaccine hesitancy threaten this goal. In a cross-country analysis of vaccine hesitant respondents across Latin America in January 2021, we experimentally tested how fiv...e features of mass vaccination campaigns—the vaccine’s producer, efficacy, endorser, distributor, and current population uptake rate—shifted willingness to take a COVID-19 vaccine. We find that citizens preferred Western-produced vaccines, but were highly influenced by factual information about vaccine efficacy. Vaccine hesitant individuals were more responsive to vaccine messengers with medical expertise than political, religious, or media elite endorsements. Citizen trust in foreign governments, domestic leaders, and state institutions moderated the effects of the campaign features on vaccine acceptance. These findings can help inform the design of unfolding mass inoculation campaigns.more
Guidance for clinical case management of thrombosis syndrome with thrombocytopenia (TTS) following vaccination to prevent coronavirus disease (COVID-19)
Interim guidance 19 July 2021
Rabies is a devastating and societally important zoonotic disease, which is transmitted principally to humans through the bite of infected dogs. This acute, progressive viral encephalitis has the highest case fatality of any infectious disease and kills tens of thousands of people annually, with chi...ldren and impoverished communities being affected disproportionately.more
The full-scale invasion of Ukraine has caused a deterioration in the level of access to health-care services and medicines in the country, particularly for people living in regions close to the front line and areas that are not partially or fully controlled by the Government of Ukraine, and for peop...le who have been internally displaced. Cost and time constraints involved in getting to and from health facilities, as well as limited transportation options were the main barriers to accessing essential health-care services. At the same time, the findings show that the country’s health system remains resilient and that overall access to health services is fairly high.This report is based on data collected through a quantitative cross-sectional survey of self-reported health needs of the general population in Ukraine. It presents results of the first round survey conducted in September 2022 and could help to address the specific health-care needs of the population groups concerned.more
Rabies remains an under-reported neglected zoonosis with a case-fatality rate of almost 100% in humans and animals. Dog-mediated human rabies causes tens of thousands of human deaths annually despite being 100% preventable. More than 95% of human cases are caused by the bite of a rabies-infected dog.... Dog-mediated human rabies disproportionately affects rural communities, particularly children, and economically disadvantaged areas of Africa and Asia, where awareness of the disease and access to appropriate post-exposure prophylaxis (PEP) can be limited or nonexistent.more
The Pharmaceutical Forum of the Americas (PFA) has previously published guidelines and organised campaigns for community pharmacists on the prevention, detection and control of arbovirus infections in 2018 with a grant from the FIP Foundation for Pharmacy Education and Research. Building on that exp...ertise, FIP joined efforts with the PFA and is now publishing its first-ever handbook to support pharmacists in the
area of vector-borne diseases. As the integration of the regional forums in FIP advances, such collaborative projects are tangible results of an increasingly regionally informed and regionally targeted work by FIP.more
A lot has happened this year. While we continued to tackle the COVID-19 pandemic, we were hit by disease outbreaks and
humanitarian crises. Yet, despite these challenges, we marched on, resolute in resolving critical health systems issues to increase
access to quality healthcare services. To furth...er our vision and bring concrete actions to reality, under
the leadership of the Government of South Sudan, we developed the Health Sector Strategic Plan to define the strategic
approaches, key interventions, mapping resource needs, and the implementation framework to strengthen the health system
to deliver essential quality health services equitably for 2023 to 2027. For WHO, this Plan will usher in a new reality -- access
to lifesaving or health-promoting interventions is doable and possible, making the health sector fairer, especially for those
unable to paymore
The Pandemic Influenza Pandemic (PIP) Framework's Partnership Contribution (PC) High-Level Implementation Plan III (HLIP III) outlines the strategy for strengthening global pandemic influenza preparedness from 2024 to 2030. HLIP III takes into consideration the lessons learned from the response to t...he COVID-19 pandemic, the gains made over time, including from previous HLIPs, and the broader programmatic and policy context in order to address gaps in pandemic influenza preparedness. Implementation of HLIP III will strengthen global, regional, and country-level pandemic influenza preparedness.more
The report aims to capture lessons from the COVID-19 pandemic and to highlight the opportunity for more ambitious global action: expanding sustainable access to vaccines for all towards the Immunization Agenda 2030 and pandemic prevention, preparedness and response efforts. The report is organized i...n two sections: the first section provides WHO insights on global vaccine market dynamics, drawing from data provided by Member States, which are, in turn, analysed and displayed in the second section.more
The GFF needs an additional US$2.5 billion from 2021 to 2025 to enable countries to protect health gains and accelerate progress toward the 2030 Goals. Of this amount, the GFF urgently needs to secure new pledges of US$1.2 billion by the end of 2021 to help its current 36 partner countries protect ...and maintain essential health services and implement time-sensitive service delivery and health system improvements to enable a sharp bend of the curve back to a positive trajectory to close the gap to the SDGs.more
Significant progress has been made in the eradication of three priority diseases in the African Region, as a result of extensive collaboration between the Regional Office, WHO country offices and countries. For example, in August 2020, the region was certified free of wild poliovirus. In the area of... neglected tropical diseases, Guinea worm disease is on the verge of eradication, and 12 member states are within reach of being certified as having eradicated yaws by the end of this year.more
In 2019, the Global Fund’s 6th Replenishment raised more than $USD14 billion to fight HIV, Tuberculosis and Malaria. Just two years later, the world has changed significantly. Put simply: COVID-19 devastated prevention and treatment programs. For the first time since the Global Fund’s founding, ...in 2020 the world lost ground in the fight against HIV, Tuberculosis and Malaria.
The Global Fund moved quickly to support countries to respond to COVID-19 and its impact on the three diseases, repurposing and leveraging additional funding to support urgent needs and adapt programs. Despite those efforts, the need for action to resume progress in the fight against HIV, TB and malaria has never been greater.
The world faces a choice.more